首頁 > 市場調查報告書 > 醫療設備 > 美國的血栓管理裝置市場：2011年

聯絡我們?

市場調查報告書

美國的血栓管理裝置市場：2011年

US Markets for Clot Management Devices 2011

出版商	Millennium Research Group
出版日期	2011年02月	商品編碼	171964
內容資訊	英文
價格	US $ 6995 Web Access and PDF Download (Single user license) US $ 10500 Web Access and PDF Download (Corporate use license)

簡介
目錄
相關商品

美國的血栓管理裝置市場：2011年 是由出版商Millennium Research Group在2011年02月所出版的。這份英文市場調查報告書價格從美金6995起跳。

簡介

2010年美國的血栓管理裝置市場，收益達到5億7000萬美元。

本報告，彙整美國的去血栓裝置、血栓溶解劑注入抽吸管、神經血管栓塞去除裝置、下腔靜脈濾器等各個產品區塊的市場動向、競爭動向等，由下列摘要形式闡述。

報告摘要

方法論

第1章美國的血栓管理裝置市場

市場概要
市場分析
- 主要更新
- 疾病概要
- 適應概要
- 處置：種類別
- 處置：適應別
- 市場預測
- 市場促進因素與限制因素
競爭分析
深度靜脈栓塞（DVT）市場

第2章經皮穿刺的去血栓裝置市場

市場概要
市場分析
- 處置
- 市場預測
- 市場促進因素與限制因素
競爭分析
- 競爭狀況
- 市佔率
- 競爭企業
- 新興企業

第3章下腔靜脈濾器市場

市場概要
市場分析
- 市場定義
- 病患數
- 處置
- 市場預測
- 市場促進因素與限制因素
競爭分析
- 競爭狀況
- 市佔率
- 競爭企業

第4章血栓溶解劑注入抽吸管市場

市場概要
市場分析
- 市場定義
- 處置
- 市場預測
- 市場促進因素與限制因素
競爭分析
- 競爭狀況
- 市佔率
- 競爭企業

第5章神經血管栓塞去除裝置

市場概要
市場分析
- 中風的概要
- 神經血管栓塞去除
- 處置
- 市場預測
- 市場促進因素與限制因素
競爭分析
- 市佔率
- 競爭企業

附錄

The US clot management device market, comprising sales of thrombectomy devices, inferior vena cava filters (IVCFs), thrombolytic infusion catheters, and neurovascular embolectomy devices, generated approximately $570 million in revenue in 2010. Percutaneous clot management devices compete with both surgical interventions and medical management for thrombosis treatment. Through 2015, adoption of these devices over surgical and/or pharmaceutical therapies will be determined primarily by conclusive, indication-specific clinical data demonstrating benefit over the current standard of care. Benefit, however, will not be measured only by technical success (i.e. thrombus removal); rather, factors such as permanence of results, patient quality of life, treatment times, and procedure cost will become increasingly important differentiating factors for clinicians. Patient preference for endovascular treatment, owing to its reduced cost, shorter hospitalization times, and reduced procedural morbidity, will also spur adoption of percutaneous clot management procedures over the forecast period. Furthermore, product innovation, particularly in the thrombectomy and neuroembolectomy device segments, will continue to drive market growth through 2015.

RESEARCH METHODOLOGY

This report uses a number of methodologies to gather and present data and analysis. At the outset, a large survey of secondary sources is conducted. These sources act as the basis for the primary research stage, which builds and enhances the quantitative and qualitative attributes of the early research.

Secondary sources include

Government sources:
- Securities and Exchange Commission filings
- Food and Drug Administration and patent filings
- National Center for Health Statistics data
Clot management device companies:
- Annual reports, product brochures, corporate profiles, etc.
Internal databases and reports:
- Previous reports on similar/related sources
General Internet searches, medical literature, and newspaper/magazine searches:
- Identifying various centers of specialization and articles that might provide leads for primary research

The secondary research stage builds the foundation for the primary research.

The primary research methodology has four steps:

Step 1: The first step involves an impartial scan of all the information gathered during the secondary research stage to determine its utility based on the specific requirements of this report. Each piece of information is either discarded or marked as high - or low -priority and then organized appropriately as determined by the structure and sectioning of the report.

Step 2: At this stage, early assumptions are formed as to the implications of the information for the various clot management device market segments. These assumptions are then used to determine hypotheses using both inductive and deductive approaches. On the quantitative front, these hypotheses result in full historical and projected market data sets (market sizes - unit sales, average selling prices [ASPs], and revenues - as well as market shares).

Step 3: At this stage, the research is in position for its most important primary phase - expert interviews. Throughout the secondary research phase, industry and medical experts are identified.

These experts are then contacted by telephone and asked to participate in interviews on recent trends and developments in the industry. Interviews are either conducted at the time of the initial call or scheduled at the convenience of the expert. Interview questions are tailored to the expertise of each particular interviewee, although in most cases, the most important questions are asked of all experts. The questions are largely based on the assumptions and hypotheses developed in Step 2, which are then augmented, discarded, or adjusted based on the views and positions put forth. Attempts are made, whenever possible, to cross -check the views of various experts against each other and to reach positions of consensus on issues and market numbers.

In addition, a sample of relevant physicians (interventional radiologists, vascular surgeons, cardiothoracic surgeons, and interventional cardiologists) is surveyed using an online questionnaire. Physicians are asked to comment on various issues/trends, both in their own practice and in the overall market. The responses provided are then used to strengthen or augment the assumptions and hypotheses developed during the primary research phase.

Step 4: The final stage of primary research involves individual and group analysis by Millennium Research Group. All research results are assessed and cross-checked thoroughly to determine their validity, relevance, and weight. From this process, qualitative conclusions are reached and data points finalized.

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

METHODOLOGY

1.0 US CLOT MANAGEMENT DEVICE MARKET

1.1 Market Overview
1.2 Market Analysis
- 1.2.1 Key Report Updates
- 1.2.2 Disease Overview
- 1.2.3 Indication Overview
  - 1.2.3.1 Arteriovenous Thrombosis
  - 1.2.3.2 Peripheral Arterial Occlusion
  - 1.2.3.3 Venous Thromboembolism
    - Deep Vein Thrombosis
    - Pulmonary Embolism
  - 1.2.3.4 Coronary Thrombosis
  - 1.2.3.5 Acute Ischemic Stroke
- 1.2.4 Procedures by Type
  - 1.2.4.1 Thrombectomy
  - 1.2.4.2 Inferior Vena Cava Filter Placement
  - 1.2.4.3 Catheter -Directed Thrombolysis
  - 1.2.4.4 Neuroembolectomy
- 1.2.5 Procedures by Indication
- 1.2.6 Market Forecast
- 1.2.7 Market Drivers and Limiters
1.3 Competitive Analysis
- 1.3.1 Competitive Landscape
- 1.3.2 Market Shares
1.4 Market Focus on Deep Vein Thrombosis
- 1.4.1 Treatment Algorithm for Deep Vein Thrombosis Patients
- 1.4.2 Key Ongoing Clinical Trials
- 1.4.3 End -User Insights: Key Limiters of DVT Treatment
- 1.4.4 Growth Drivers of Deep Vein Thrombosis Treatment

2.0 PERCUTANEOUS THROMBECTOMY DEVICE MARKET

2.1 Market Overview
2.2 Market Analysis
- 2.2.1 Procedures
  - 2.2.1.1 Mechanical
  - 2.2.1.2 Pharmacomechanical
  - 2.2.1.3 Aspiration
- 2.2.2 Market Forecast
  - 2.2.2.1 Mechanical Thrombectomy Device Market
  - 2.2.2.2 Pharmacomechanical Thrombectomy Device Market
  - 2.2.2.3 Aspiration Catheter Market
- 2.2.3 Market Drivers and Limiters
2.3 Competitive Analysis
- 2.3.1 Competitive Landscape
- 2.3.2 Market Shares
- 2.3.3 Competitor Discussions (in Alphabetical Order)
  - Arrow International (a Teleflex Medical Company)
  - Covidien (including Bacchus Vascular)
  - EKOS
  - ev3 (acquired by Covidien)
  - MEDRAD Interventional/Possis
  - Medtronic
  - Spectranetics
  - Vascular Solutions
  - Other
- 2.3.4 Emerging Competitors
  - Kaneka (distributed by Atrium Medical)

3.0 INFERIOR VENA CAVA FILTER MARKET

3.1 Market Overview
3.2 Market Analysis
- 3.2.1 Market Definitions
- 3.2.2 Patient Populations
  - 3.2.2.1 DVT Treatment
  - 3.2.2.2 VTE Prophylaxis
- 3.2.3 Procedures
- 3.2.4 Market Forecast
  - 3.2.4.1 Retrievable Inferior Vena Cava Filter Market
  - 3.2.4.2 Permanent Inferior Vena Cava Filter Market
- 3.2.5 Market Drivers and Limiters
3.3 Competitive Analysis
- 3.3.1 Competitive Landscape
- 3.3.2 Market Shares
- 3.3.3 Competitor Discussions (in Alphabetical Order)
  - ALN
  - B. Braun
  - Boston Scientific
  - Cook Medical
  - Cordis
  - C. R. Bard
  - Rafael Medical Technologies
  - Rex Medical (distributed by Angiotech)

4.0 THROMBOLYTIC INFUSION CATHETER MARKET

4.1 Market Overview
4.2 Market Analysis
- 4.2.1 Market Definitions
  - 4.2.1.1 Thrombolytic Therapy
- 4.2.2 Procedures
  - 4.2.2.1 Peripheral Catheter -Directed Thrombolysis
  - 4.2.2.2 Coronary Catheter -Directed Thrombolysis
  - 4.2.2.3 Intra -Arterial Thrombolysis for AIS Treatment
- 4.2.3 Market Forecast
- 4.2.4 Market Drivers and Limiters
4.3 Competitive Analysis
- 4.3.1 Competitive Landscape
- 4.3.2 Market Shares
- 4.3.3 Competitor Discussions (in Alphabetical Order)
  - AngioDynamics
  - Cook Medical
  - EKOS
  - ev3 (acquired by Covidien)
  - Merit Medical Systems
  - Other

5.0 NEUROEMBOLECTOMY DEVICE MARKET

5.1 Market Overview
5.2 Market Analysis
- 5.2.1 Stroke Overview
  - 5.2.1.1 Treatment of Acute Ischemic Stroke
- 5.2.2 Neuroembolectomy
- 5.2.3 Procedures
- 5.2.4 Market Forecast
- 5.2.5 Market Drivers and Limiters
5.3 Competitive Analysis
- 5.3.1 Competitive Landscape
- 5.3.2 Market Shares
- 5.3.3 Competitor Discussions (in Alphabetical Order)
  - Concentric Medical
  - ev3 (acquired by Covidien)
  - Penumbra
  - Other

APPENDIX A: MRG ACRONYMS AND INITIALISMS

APPENDIX B: SUPPLEMENTAL FIGURES